Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
09 déc. 2024 07h00 HE
|
Universe Pharmaceuticals INC.
Jiangxi, China, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (Nasdaq: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China today...
Universe Pharmaceuticals INC Announces Share Consolidation
13 nov. 2024 08h00 HE
|
Universe Pharmaceuticals INC.
Jiangxi, China, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today...
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
01 nov. 2024 16h00 HE
|
Universe Pharmaceuticals INC.
Ji’an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the...
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
20 sept. 2024 16h15 HE
|
Universe Pharmaceuticals INC.
JI’AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today...